ACoP Special Session-The Future is Now: Envisioning the Next Era of Pharmacometrics

Chair(s)

• LH

  Lora Hamuro

  Disclosure information not submitted.

  PDF Slides
• SG

  Stephen Greene

  Disclosure information not submitted.

Panelist(s)

• 

  Hao Zhu, PhD

  ISoP Board Member
  ISoP, Maryland, United States

  Disclosure(s): No financial relationships to disclose
• CM

  C.J. Musante, PhD

  VP & Global Head of Pharmacometrics & Systems Pharmacology
  Pfizer

  Disclosure(s): Pfizer: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Mark Dresser (he/him/his)

  Senior Vice President
  Gilead Sciences

  Disclosure information not submitted.
• 

  Liang Zhao, PhD (he/him/his)

  Professor
  Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF, United States

  Disclosure(s): No financial relationships to disclose